跳至主要内容
临床试验/NCT05905848
NCT05905848尚未招募3 期

Pre-operative Antihypertensive Drugs and Persistent Hypotension in Carotid Artery Stenting Comorbid With Hypertension Patients --- a Multicenter, Randomized, Open Label, Blinded Ended Point Clinic Trail

West China Hospital1 个研究点 分布在 1 个国家目标入组 560 人开始时间: 2023年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
入组人数
560
试验地点
1
主要终点
The incidence of persistent post-surgery hypotension

研究概览

简要总结

Carotid artery stenting (CAS) is one of major treatments in prevention of ischemic stroke. Because of sinus reflex due to stenting and balloon dilatation, persistent post-surgery hypotension is a common perioperative event. Persistent hypotension can lead to perioperative adverse events like ischemic stroke, myocardial infraction, renal failure and death; or more usually, it prolongs length of stay and hospital expenses. Renin-angiotensin-aldosterone inhibitor (RASI) could inhibit the release of catecholamine and may lead to higher rate of persistent hypotension after CAS compared to other hypertensives.Thus, the investigators aim to investigate the effect of pre-operation antihypertensive drugs on persistent hypotension after stenting, and followed burden in carotid artery stenting comorbid with hypertension patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

open label, blinded endpoint

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • have a history of TIA or nondisabling ischemic stroke within the past 6 months (symptomatic) with ipsilateral initial part of EICA stenosis ≥ 50 % or asymptomatic with initial part of EICA stenosis ≥ 70%, and the cause of stenosis was atherosclerosis
  • have hypertension requiring hypertensives
  • modified Rankin scale (mRS) before stenting < 3

排除标准

  • with ipsilateral tandem stenosis
  • with history of operation in contralateral carotid artery, like stenting, endarterectomy and bypass.
  • requiring operation in contralateral carotid artery in the same admission.
  • requiring general anesthesia in the same operation (stenting)
  • with contraindication to carotid stenting, such as Inability to tolerate surgery due to organ dysfunction, cerebral aneurism, cerebral hemorrhage in 3 months, myocardial infraction or large-area cerebral infraction within 2 weeks, extreme tortuosity of the vessel
  • allergic to Calcium channel blockers, angiotensin receptor blockers or hydrochlorothiazide
  • pregnancy
  • with concomitant medication as following: Azole antifungals, macrolides antibiotics, cardiac calcium channel blockers, Rifampicin, sildenafil, simvastatin, immunosuppressants, antidepressants, valproic acid, cimetidine, aliskiren, NSAIDs, protease inhibitors (ritonavir) and drugs that affect potassium in the blood
  • with hepatic insufficiency, renal insufficiency, kidney transplantation, diabetic nephropathy, biliary obstructive disease, or the presence of end-stage disease affecting clinical prognosis assessment (such as end-stage cancer, end-stage heart disease, liver failure, renal failure, pulmonary failure)
  • with depression, schizophrenia, bipolar disorder, epilepsy, tuberculosis, AIDS, primary hyperaldosteronism, hyperkalemia, hypercalcemia, hyperuricemia, gout
  • participating other trails which would affect the evaluation of outcomes
  • with reserpine and clonidine intake within 1 week

研究组 & 干预措施

RASI group

Experimental

Administer RASI, with or without other antihypertensives except for CCB, and blood pressure should be controlled within the target range (140/90 mmHg). RASI intaking starts at least 5 days before stenting.

干预措施: administering RASI (the trade name or universal name will not be stipulated) before stenting (Drug)

CCB group

Active Comparator

Administer CCB, with or without other antihypertensives except for RASI, and blood pressure should be controlled within the target range (140/90 mmHg). CCB intaking starts at least 5 days before stenting.

干预措施: administering CCB (the trade name or universal name will not be stipulated) before stenting (Drug)

结局指标

主要结局

The incidence of persistent post-surgery hypotension

时间窗: the first 24 hours after CAS

systolic blood pressure (SBP) \< 90 mmHg or requiring vasopressor with lasting \> 6 hours, and without evidence hypovolemia and heart failure

次要结局

  • Length of stay after surgery(From surgery to dicharge, up to 3 month.)
  • Hospital expenses after surgery, based on payment list in hospital information system(From surgery to dicharge, up to 3 month.)
  • Difference of serum catecholamine (adrenalin, norepinephrine and dopamine) before and after surgery (all in unit of nmol/L)(at morning (7 o'clock am) of the day of surgery and the first day after surgery)
  • Difference of heart rate variability (HRV) before and after surgery(24 hours before surgery to at least 24 hours after surgery)
  • The incidence of bradycardia after surgery(the first 24 hours after CAS)
  • The total incidence of stroke, myocardial infraction, renal failure and embolism of retinal arteries(From surgery to dicharge, up to 3 month.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bo Wu

Professor/Deputy Director of Neurology of West China Hospital, Sichuan University

West China Hospital

研究点 (1)

Loading locations...

相似试验